Pre-Visit AI Symptom-Checking and Shared Decision-Making in Spine Physical Therapy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

Artificial intelligence (AI) symptom-checking tools, including large language models such as ChatGPT, are increasingly used by patients before they seek care. These tools may shape patients' beliefs about their diagnosis, how serious they think their condition is, and when they decide to seek treatment. It is not yet known how this pre-visit AI use affects the initial physical therapy encounter for spine-related problems.

This prospective observational cohort study examines whether prior use of AI symptom-checking tools influences the first physical therapy evaluation in adults presenting with spine-related musculoskeletal complaints (neck, thoracic, or low back pain, with or without radicular symptoms). Consecutive patients attending an outpatient physical therapy clinic for a new evaluation are grouped as AI users or non-AI users based on whether they used such a tool for their current complaint in the previous 30 days.

The primary outcome is shared decision-making, measured with the SDM-Q-9 immediately after the initial evaluation. Secondary outcomes include stage of presentation, agreement between the patient's expected diagnosis and the clinician's classification, baseline pain and disability, functional performance, and clinical outcomes at 2 and 6 weeks. The investigators hypothesize that prior AI use is associated with differences in shared decision-making and in how patients present for care.

Eligibility criteria

Qualifiers

Age: 18 years or older

Presenting for a new evaluation at an outpatient physical therapy clinic for a spine-related musculoskeletal complaint, including Neck, Thoracic, and Low back pain With or without radicular symptoms

Able to provide informed consent.

Able to read, understand, and complete study questionnaires

Disqualifiers

Recent spinal surgery within the past 3 months, due to differing clinical pathways and management strategies.

Cognitive impairment or other conditions that limit the ability to provide informed consent or reliably complete study measures.

Patients currently enrolled in another study that may influence clinical decision-making or outcomes related to spine care.

Trial design

Treatments tested in this trial

  • re-visit AI symptom-checker use

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators